Cambridge Investment Research Advisors’s iShares MSCI Switzerland ETF EWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Sell
3,247
-168
-5% -$10.3K ﹤0.01% 3816
2026
Q1
$201K Hold
3,415
﹤0.01% 3675
2025
Q4
$205K Buy
+3,415
New +$196K ﹤0.01% 3564
2022
Q1
Sell
-59,961
Closed -$3.16M 3203
2021
Q4
$3.16M Sell
59,961
-811
-1% -$40.6K 0.01% 890
2021
Q3
$2.83M Sell
60,772
-8,160
-12% -$405K 0.01% 903
2021
Q2
$3.35M Buy
+68,932
New +$3.29M 0.02% 831
2018
Q2
Sell
-6,408
Closed -$220K 2212
2018
Q1
$220K Buy
+6,408
New +$228K ﹤0.01% 1905
2014
Q2
Sell
-6,252
Closed -$215K 1346
2014
Q1
$215K Buy
+6,252
New +$208K 0.01% 1125

Other funds holding EWL

Cambridge Investment Research Advisors's EWL Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its iShares MSCI Switzerland ETF (EWL) stake by 4.9% in Q2 2026, selling an estimated $10.3K and leaving 3,247 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #3816.

Cambridge Investment Research Advisors first reported a position in EWL in Q1 2014 and has held it in 8 quarters since. The position peaked at $3.35M in Q2 2021. 194 funds tracked by Wall St. Rank hold EWL as of Q2 2026.

  • Cambridge Investment Research Advisors held 3,247 shares of iShares MSCI Switzerland ETF worth $204K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 168 iShares MSCI Switzerland ETF shares in Q2 2026, an estimated $10.3K.
  • iShares MSCI Switzerland ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3816 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares MSCI Switzerland ETF in Q1 2014 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's iShares MSCI Switzerland ETF position peaked at $3.35M in Q2 2021.
  • 194 funds tracked by Wall St. Rank held iShares MSCI Switzerland ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.